Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Next Stem Cell President Should be Hands-on, Scientific Administrator; Consumer Advocates Urge

Published: Monday, February 05, 2007
Last Updated: Monday, February 05, 2007
Bookmark and Share
Focusing on big names could result in hiring a figurehead rather than an executive committed to making the stem cell institute work in the public's best interest.

California's stem cell oversight committee should focus on finding a competent, hands-on administrator to replace retiring Dr. Zach Hall as president of the California Institute for Regenerative Medicine (CIRM), said the Foundation for Taxpayer and Consumer Rights (FTCR).

"Members of the search committee should avoid the temptation of seeking a 'big-name' scientist known for his or her discoveries," said John M. Simpson, FTCR Stem Cell Project Director. "The emphasis must be on the individual's skills in scientific management and administration."

Focusing on big names could result in hiring a figurehead rather than an executive committed to making the stem cell institute work in the public's best interest, FTCR said.

The presidential search committee meets at 3 p.m. Wednesday, Jan. 31, in San Francisco. In a letter to Robert Klein committee chairman, Simpson said that Dr. Hall had exemplified the qualities necessary for the position during his two years in the job.

"The next president must be an extremely competent hands-on scientific administrator, who can set up and maintain transparent and accountable management systems," Simpson wrote. "He or she must be able to interact with the public, state officials, legislators and the media in a transparent, honest and accountable fashion."

In the past there have been suggestions that the president of the California Institute for Regenerative Medicine (CIRM) might continue to maintain a research laboratory as part of the president's role. This should not be allowed, FTCR said.

"The presidency of CIRM is more than a full-time job, "said Simpson.”A person trying to manage CIRM's activities and conduct meaningful research simultaneously would do justice to neither activity."

Finally, while there are a number of individuals on the ICOC itself who have performed admirably in their positions as scientific administrators, FTCR said CIRM's interests would be best served if the search does not consider them and looks beyond the oversight committee.

Dr. Hall announced at the stem cell oversight committee's December meeting that he wished to retire within six months.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

California Stem Cell Agency Exaggerated its Role in Funding Key Research
California's stem cell agency overstated and hyped the importance of its funding in enabling clinical trials for a drug to treat a severe blood disorder.
Thursday, April 17, 2008
CIRM to Announce new Faculty Awards to Fund Next Generation of Stem Cell Scientists
CIRM will announce up to $85 million in New Faculty Awards at the December 12 meeting of its governing body, the Independent Citizens Oversight Committee.
Tuesday, December 11, 2007
Stem Cell Research Headed by $45 Million in California
The 29-member Independent Citizens Oversight approves 72 grants to researchers at 20 academic and non-profit research centers throughout the state.
Friday, February 23, 2007
Scientific News
Common Cell Transformed into Master Heart Cell
By genetically reprogramming the most common type of cell in mammalian connective tissue, researchers at the University of Wisconsin—Madison have generated master heart cells — primitive progenitors that form the developing heart.
Improving Regenerative Medicine
Lab-created stem cells may lack key characteristics, UCLA research finds.
Muscles on-a-Chip
This study may help explain why stem cell-based therapies have so far shown limited benefits for heart attack patients in clinical trials.
3-D Printed Lifelike Liver Tissue for Drug Screening
A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cat Stem Cell Therapy Gives Humans Hope
By the time Bob the cat came to the UC Davis veterinary hospital, he had used up most of his nine lives.
Bile Acid Supports Production of Blood Stem Cells
A research group at Lund University has been able to show that bile acid is transferred from the mother to the foetus via the placenta to enable the foetus to produce blood stem cells.
New Biomarker to Assess Stem Cells Developed
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Edited Stem Cells Offer Hope of Precision Therapy for Blindness
Findings raise the possibility of treating blinding eye diseases using a patient's own corrected cells as replacement tissue.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!